INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 128 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2016. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $276,000 | -60.7% | 18,088 | 0.0% | 0.12% | -63.8% |
| Q2 2016 | $702,000 | +39.6% | 18,088 | 0.0% | 0.33% | +37.1% |
| Q1 2016 | $503,000 | +102.8% | 18,088 | +292.1% | 0.24% | +101.7% |
| Q4 2015 | $248,000 | -52.0% | 4,613 | -64.3% | 0.12% | -54.8% |
| Q3 2015 | $517,000 | -24.9% | 12,913 | -40.0% | 0.26% | -15.7% |
| Q2 2015 | $688,000 | +33.9% | 21,518 | 0.0% | 0.31% | +32.8% |
| Q1 2015 | $514,000 | – | 21,518 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |